Orthogon Therapeutics
Canton · Biotechnology, Health Care, Information Technology
Orthogon Therapeutics is a privately held R&D company. Orthogon uses structure-based drug design and biophysics to successfully optimize drugs that bind selectively and safely neutralize target proteins that have been considered difficult to “drug”. The Company was founded by a veteran biotech entrepreneur and experienced drug discovery scientists with a mission to prolong and improve patient qual
Key facts
- Headquarters
- Canton
- Employees
- 3
- Industries
- Biotechnology, Health Care, Information Technology
- Status
- Private
- Website
- orthogontherapeutics.com
- Company page
Recent activity at Orthogon Therapeutics
Orthogon Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Apr 2026 | Funding Round | $11.0M |
| Dec 2024 | Funding Round | $5.2M |
Leadership
- Vipul Chitalia, Director
- Hector Lucero, Director
- Ali Munawar, Chief Executive Officer
Verified email and direct lines for Orthogon Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Orthogon Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Orthogon Therapeutics in the news
Companies similar to Orthogon Therapeutics
- LIXTE Biotechnology Holdings · Biotechnology, Health Care, Information Technology, Science And Engineering
- Specific Biologics · Biotechnology, Health Care, Information Technology, Science And Engineering
- Viracta Therapeutics · Biotechnology, Health Care, Information Technology, Science And Engineering
- Variantyx · Biotechnology, Health Care, Information Technology, Science And Engineering
- 22nd Century · Biotechnology, Health Care, Information Technology, Science And Engineering
About Orthogon Therapeutics: questions and answers
What does Orthogon Therapeutics do?
Orthogon Therapeutics is a privately held R&D company. Orthogon uses structure-based drug design and biophysics to successfully optimize drugs that bind selectively and safely neutralize target proteins that have been considered difficult to “drug”. The Company was founded by a veteran biotech entrepreneur and experienced drug discovery scientists with a mission to prolong and improve patient qual
Where is Orthogon Therapeutics headquartered?
Orthogon Therapeutics is headquartered in Canton.
How many employees does Orthogon Therapeutics have?
Orthogon Therapeutics has about 3 employees.
Has Orthogon Therapeutics raised funding?
Yes. Fundz has recorded 2 funding events for Orthogon Therapeutics. The most recent, Funding Round of $11.0M, was in Apr 2026.
Who leads Orthogon Therapeutics?
Ali Munawar is a Chief Executive Officer at Orthogon Therapeutics.
What is the latest news on Orthogon Therapeutics?
On Apr 17, 2026, Orthogon Therapeutics raises $11M in a funding round for its BK virus antiviral drug program, bringing total funding to $36M.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy